OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
Emmanuel Wey, Clare Bristow, Aarti Nandani, et al.
Journal of Infection (2021) Vol. 83, Iss. 5, pp. 607-635
Open Access | Times Cited: 6
Emmanuel Wey, Clare Bristow, Aarti Nandani, et al.
Journal of Infection (2021) Vol. 83, Iss. 5, pp. 607-635
Open Access | Times Cited: 6
Showing 6 citing articles:
Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
Cori Campbell, Monique Andersson, M. Azim Ansari, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 33
Cori Campbell, Monique Andersson, M. Azim Ansari, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 33
Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study
Melanie Nana, Maria Gregori, E. Chandler, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 9, pp. e625-e635
Closed Access | Times Cited: 3
Melanie Nana, Maria Gregori, E. Chandler, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 9, pp. e625-e635
Closed Access | Times Cited: 3
Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study
Fergus Hamilton, Haiko Schurz, Tom Yates, et al.
The Lancet Microbe (2024), pp. 100922-100922
Open Access | Times Cited: 1
Fergus Hamilton, Haiko Schurz, Tom Yates, et al.
The Lancet Microbe (2024), pp. 100922-100922
Open Access | Times Cited: 1
C-reactive protein-guided use of procalcitonin in COVID-19
Rebecca Houghton, Nathan Moore, Rebecca Williams, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 11
Rebecca Houghton, Nathan Moore, Rebecca Williams, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 11
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19
Francesco Scavello, Enrico Brunetta, Sarah N Mapelli, et al.
EBioMedicine (2024) Vol. 105, pp. 105213-105213
Open Access
Francesco Scavello, Enrico Brunetta, Sarah N Mapelli, et al.
EBioMedicine (2024) Vol. 105, pp. 105213-105213
Open Access
FEATURES OF THE USE OF ANTIBACTERIAL DRUGS IN PATIENTS WITH COVID-19
A. V. Kryukov, E. V. Kuznetsova, I. I. Temirbulatov, et al.
Problems of Social Hygiene Public Health and History of Medicine (2022) Vol. 30, Iss. s1, pp. 1044-1049
Open Access
A. V. Kryukov, E. V. Kuznetsova, I. I. Temirbulatov, et al.
Problems of Social Hygiene Public Health and History of Medicine (2022) Vol. 30, Iss. s1, pp. 1044-1049
Open Access
